GREENSBORO, N.C., Nov. 15, 2021 /PRNewswire/ — A United States patent has been filed for an unprecedented application of nanoparticles as a safe, effective and discreet contraceptive. One of the patent-pending formulations would allow for continuous protection from as few as 2 applications per week with a biologically neutral contraceptive.
Read the Press Release Here: https://www.prnewswire.com/news-releases/novel-contraceptive-by-at-research-partners-promises-efficacy-access-and-safety-for-women-using-nanotechnology-301423284.html
AT Research Partners 
Leave a comment